#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	25220	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2145	1153.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1398	1398	C	1458	C,T	1424,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	46292	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3719	1228.9	0	.	n	.	0	A20C	SNP	20	20	A	434	434	C	968	C,A	604,344	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	46292	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3719	1228.9	0	.	n	.	0	T695C	SNP	695	695	T	1109	1109	C	1351	C	1318	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	46292	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3719	1228.9	0	.	n	.	0	A1638G	SNP	1638	1638	A	2052	2052	G	1454	G,A	1409,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	46292	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3719	1228.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2385	2385	C	1504	C,T	1449,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	46292	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3719	1228.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2459	2459	A	1418	A	1395	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	46292	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3719	1228.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3011	3011	C	1407	C,T,G	1367,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	512	16	blaTEM	861	209	99.52	blaTEM.l15.c4.ctg.1	227	2.0	0	.	p	.	0	P12S	NONSYN	34	36	CCC	52	54	TCC	1;1;1	T;C;C	1;1;1	.	Betalactam resistance
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	512	16	blaTEM	861	149	100.0	blaTEM.l15.c4.ctg.2	258	1.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	3414	folP	855	855	100.0	folP.l15.c4.ctg.1	1582	213.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1019	1021	AGC	330;333;335	A;G;C	323;325;328	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	9470	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3393	275.0	1	SNP	p	S91F	1	.	.	271	273	TTC	574	576	TTC	289;287;289	T;T;C	281;279;275	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	9470	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3393	275.0	1	SNP	p	D95G	1	.	.	283	285	GGC	586	588	GGC	293;294;292	G;G;C	282;285;282	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	9470	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3393	275.0	1	SNP	p	G95N	0	.	.	283	285	GGC	586	588	GGC	293;294;292	G;G;C	282;285;282	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	2862	mtrR	633	633	99.84	mtrR.l6.c4.ctg.1	1341	210.7	0	.	p	.	0	F184L	NONSYN	550	552	TTC	894	896	TTG	302;298;299	T,C;T;G,C	290,1;290;287,1	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	2862	mtrR	633	633	99.84	mtrR.l6.c4.ctg.1	1341	210.7	1	SNP	p	G45D	0	.	.	133	135	GGC	477	479	GGC	361;360;359	G;G;C	353;351;351	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1604	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	996	159.8	0	.	n	.	0	A197.	DEL	197	197	A	591	591	A	376	A	368	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8598	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3050	277.4	1	SNP	p	D86N	0	.	.	256	258	GAC	718	720	GAC	331;331;333	G;A,C;C	322;310,1;327	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8598	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3050	277.4	1	SNP	p	S87R	1	.	.	259	261	CGT	721	723	CGT	329;333;338	C;G;T	325;327;327	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8598	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3050	277.4	1	SNP	p	R87I	0	.	.	259	261	CGT	721	723	CGT	329;333;338	C;G;T	325;327;327	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8598	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3050	277.4	1	SNP	p	R87W	0	.	.	259	261	CGT	721	723	CGT	329;333;338	C;G;T	325;327;327	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8598	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3050	277.4	1	SNP	p	S88P	0	.	.	262	264	TCC	724	726	TCC	334;335;338	T;C;C	327;328;336	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	7132	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2587	271.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1528	1530	GGC	337;331;330	G;G;C	326;323;321	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	6692	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2358	278.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1181	1183	GCA	353;352;355	G,T;C;A	340,1;336;345	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	6692	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2358	278.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1184	1186	ATC	357;358;357	A;T;C,A	345;348;342,2	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	6692	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2358	278.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1196	1198	GTG	360;357;352	G;T;G	350;344;345	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	6692	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2358	278.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1196	1198	GTG	360;357;352	G;T;G	350;344;345	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	6692	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2358	278.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1700	1702	ACC	304;303;307	A;C;C,T	288;290;295,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	6692	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2358	278.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1754	1756	GCG	312;313;315	G;C,G;G,A	294;262,5;298,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	6692	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2358	278.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1754	1756	GCG	312;313;315	G;C,G;G,A	294;262,5;298,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	6692	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2358	278.5	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1877	1879	AGC	268;268;263	A;G;C	256;258;254	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	6692	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2358	278.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1886	1888	GGC	247;247;246	G,A;G;C	236,1;240;237	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	6692	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2358	278.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1904	1906	CCG	183;189;188	C,G;C,G;G,C	160,3;169,1;165,2	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	9888	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3242	300.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1702	1704	CCG	356;357;350	C,G;C;G	327,1;342;332	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	4358	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1663	255.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	520	520	C	290	C	273	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	4716	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1494	310.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	414	416	GAA	385;383;384	G;A;A	367;371;369	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	4716	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1494	310.8	0	.	p	.	0	N134D	NONSYN	400	402	AAT	702	704	GAT	344;349;354	G;A;T	336;341;342	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	4716	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1494	310.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	825	827	TCA	389;390;390	T,C;C;A	374,1;377;380	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	4716	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1494	310.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	954	956	GTC	349;345;343	G;T;C	340;324;335	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	4716	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1494	310.8	0	.	p	.	0	F222S	NONSYN	664	666	TTT	966	968	TCT	345;343;342	T;C,T,G;T,C	338;334,1,1;339,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	4716	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1494	310.8	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1284	1286	GCA	371;369;366	G;C;A	356;353;349	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	4716	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1494	310.8	1	SNP	p	G120K	1	.	.	358	360	AAG	660	662	AAG	343;344;346	A;A;G	338;337;338	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	4716	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1494	310.8	1	SNP	p	D121N	0	.	.	361	363	GAC	663	665	GAC	346;337;337	G;A;C	332;321;327	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	4716	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1494	310.8	1	SNP	p	A121D	1	.	.	361	363	GAC	663	665	GAC	346;337;337	G;A;C	332;321;327	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	16330	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4851	331.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1862	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1052	174.7	1	SNP	p	V57M	1	.	.	169	171	ATG	474	476	ATG	353;353;355	A;T;G,T	343;341;341,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
